Grant Reilly
27th January 2021
Back
DHI was delighted to be informed that Manus Neurodynamica and their project we provided a letter of support and in-kind support for has secured £1.2 million in funding to accelerate the roll-out of a digital pen designed to detect the early onset of Parkinson's disease.
With this latest funding secured, Manus is rolling-out its NeuroMotor PenTM later this year, initially focusing on the UK and Benelux markets, while also progressing work to secure regulatory approval to start selling in US. Around 145,000 people live with Parkinson’s in the UK and it’s the fastest-growing neurological condition in the world.
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. For more information read our Privacy Notice and Cookies Policy.
Click Continue if you consent to use all non-essential cookies or choose your own cookie settings.